State of New Jersey Common Pension Fund D Purchases Shares of 31,788 Tempus AI, Inc. $TEM

State of New Jersey Common Pension Fund D purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 31,788 shares of the company’s stock, valued at approximately $2,020,000.

Several other institutional investors have also added to or reduced their stakes in the business. Concord Wealth Partners grew its holdings in shares of Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after purchasing an additional 308 shares during the last quarter. University of Texas Texas AM Investment Management Co. bought a new position in shares of Tempus AI in the first quarter worth approximately $33,000. Nemes Rush Group LLC bought a new position in shares of Tempus AI in the first quarter worth approximately $39,000. Quarry LP bought a new position in shares of Tempus AI in the first quarter worth approximately $44,000. Finally, Signaturefd LLC bought a new position in shares of Tempus AI in the first quarter worth approximately $48,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 3,664 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the transaction, the executive vice president owned 94,115 shares of the company’s stock, valued at approximately $7,025,684.75. The trade was a 3.75% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO James William Rogers sold 7,528 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the transaction, the chief financial officer directly owned 138,473 shares of the company’s stock, valued at approximately $10,337,009.45. This trade represents a 5.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 1,099,912 shares of company stock valued at $87,247,931 over the last ninety days. Corporate insiders own 26.27% of the company’s stock.

Tempus AI Stock Performance

Shares of TEM stock opened at $86.27 on Friday. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $104.32. The stock has a market cap of $14.99 billion, a PE ratio of -72.50 and a beta of 4.87. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The company’s fifty day moving average price is $85.24 and its 200-day moving average price is $69.15.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The firm had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI’s quarterly revenue was up 89.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on TEM shares. BTIG Research raised their target price on shares of Tempus AI from $85.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Canaccord Genuity Group started coverage on shares of Tempus AI in a report on Monday, October 20th. They issued a “buy” rating and a $110.00 target price on the stock. Piper Sandler raised their target price on shares of Tempus AI from $70.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, October 22nd. Finally, Morgan Stanley raised their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a report on Tuesday, August 12th. Seven equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $79.38.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.